Additional file 1 of Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy

Additional file 1 of Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy

Additional file 1. Contains supplementary table Tab. S1: HLA class I and II restricted peptides from the 113 candidate genes identified by HLA ligandomics in patient cohort 1 (n = 55).

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Reustle, Anna, Di Marco, Moreno, Meyerhoff, Carolin, Nelde, Annika, Walz, Juliane S., Winter, Stefan, Kandabarau, Siahei, Büttner, Florian, Haag, Mathias, Backert, Linus, Kowalewski, Daniel J., Rausch, Steffen, Hennenlotter, Jörg, Stühler, Viktoria, Scharpf, Marcus, Fend, Falko, Stenzl, Arnulf, Rammensee, Hans-Georg, Bedke, Jens, Stevanović, Stefan, Schwab, Matthias, Schaeffeler, Elke
Format: Dataset
Sprache:eng
Schlagworte:
FOS: Biological sciences
FOS: Clinical medicine
Genetics
Immunology
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Additional file 1. Contains supplementary table Tab. S1: HLA class I and II restricted peptides from the 113 candidate genes identified by HLA ligandomics in patient cohort 1 (n = 55).
DOI:10.6084/m9.figshare.12050598